The Economist – A story exploring research from Steven Woloshin and Lisa Schwartz who have been studying how marketing advertisers target middle-aged men with low testosterone, or “low T.”

The Wall Street Journal – In an opinion piece for the Journal’s “The Experts” blog, Elliott Fisher responds to the question “What is the biggest mistake patients make when picking a primary-care doctor?”

NPR – Continued coverage of a Dartmouth study led by H. Gilbert Welch that attributes a drastic increase in thyroid cancer cases to overdiagnosis, leading to overtreatment.

The New York Times – Quotes Louise Davies, an assistant professor of surgery and of TDI, who says diagnosing patients with thyroid cancer who have small tumors “distracts from the problem they came in with and leads to unnecessary treatment.”

NPR – Steven Woloshin and Lisa Schwartz are quoted extensively on the Food and Drug Administration’s call for research into how prescription drug ads can be improved. Schwartz’s research on two new weight-loss drugs with harmful side effects is also discussed. Schwartz and Woloshin are both professors of medicine and of community and family medicine, as well as co-directors of the Medicine and the Media program. This story was published by NPR’s Shots.

Bloomberg – Points to research from the Dartmouth Atlas which Bloomberg says has “shown time and again that some of the biggest and best-known U.S. hospitals are no less guilty of subjecting patients to useless tests and marginal treatments.”

Novus Media Today – A story on a new MRI/near-infrared spectroscopy (NIRS) method developed by researchers at the Geisel School of Medicine.

Los Angeles Times – In this op-ed, Steven Woloshin and Lisa Schwartz discuss a recent article they wrote in JAMA Internal Medicine that looks at how marketing advertisers target middle-aged men with low testosterone, or “low T.”

The New York Times– In this op-ed, Associate Professor of Medicine Tim Lahey looks at the ethics of video monitoring patients and staff in hospitals. “Hidden cameras should be a last resort,” writes Lahey. “Hospitals should notify patients that covert video monitoring may be used in unusual circumstances, and only with the oversight of a hospital ethics committee.”